8.1 Q&A Summary (revised)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/53

encourage image

There's no tags or description

Looks like no tags are added yet.

54 Terms

1
New cards

Define asthma

Heterogeneous chronic airway inflammation with symptoms that fluctuate and a reversible limitation of expiratory flow.

2
New cards

True or False: Asthma is reversible either on its own or after therapy.

True

3
New cards

Explain how inflammation narrows the airway.

Smooth muscle tightens and mucus production increases.

4
New cards

Describe the role of bronchial hyperresponsiveness.

It heightens the tendency for the airway to narrow.

5
New cards

Name four structural changes seen with long‑standing inflammation.

- Fibrotic extracellular matrix

- augmented smooth muscle contraction

- enlarged mucus glands

- new vessel formation.

6
New cards

Explain the concept of abnormal healing asthma

Repair processes are altered, promoting fixed changes in the airway wall.

7
New cards

Name the immunoglobulin that initiates the cascade in the acute phase of asthma

IgE.

8
New cards

Identify the two sentinel cells first activated.

Mast cells and macrophages.

9
New cards

List mediators released early in the process.

- Histamine

- eicosanoids

- reactive oxygen species.

10
New cards

Describe the immediate functional effects of acute mediators.

Airway muscle contracts, mucus is secreted, and edema develops.

11
New cards

Specify the granulocyte that is a hallmark of type‑2 airway inflammation.

Eosinophils.

12
New cards

Identify the T‑helper subset linked to protective immunity.

Th1.

13
New cards

Identify the T‑helper subset linked to allergic inflammation.

Th2.

14
New cards

State what mast cells do during chronic disease activity.

They degranulate and release cytokines and leukotrienes

15
New cards

Explain how macrophages contribute to amplification.

They digest microbes and further drive the inflammatory response.

16
New cards

Map inflammatory driver to anti‑inflammatory drug class.

Eosinophilic inflammation corresponds to inhaled corticosteroids.

17
New cards

Map bronchoconstriction to rapid bronchodilator target.

β‑adrenergic receptors correspond to β‑agonists.

18
New cards

List two additional biologic targets beyond steroids and β‑agonists.

Interleukins and IgE.

19
New cards

State the two core components needed for diagnosis.

Characteristic symptom patterns along with variable limitation of expiratory flow.

20
New cards

List frequent symptoms reported by patients.

- Wheezing

- breathlessness

- cough

- chest tightness.

21
New cards

Describe temporal features typical of symptoms.

Worse at night or on waking, vary in intensity and frequency, and often triggered.

22
New cards

List family/past history elements that raise suspicion.

Allergy, asthma in relatives, allergic rhinitis, and atopic dermatitis.

23
New cards

Identify the preferred test for airflow assessment.

Spirometry is preferred over peak flow.

24
New cards

State the ratio that indicates obstruction in adults.

FEV1/FVC < 0.75-0.8

25
New cards

State the ratio that indicates obstruction in children.

FEV1/FVC < 0.9

26
New cards

Describe patterns that demonstrate excessive variability.

Improvement after treatment, decline after exertion, or differences across visits.

27
New cards

Provide the numerical criterion for reversibility using FEV1.

At least a 20% and 200 mL rise from baseline.

28
New cards

Provide the numerical criterion for reversibility using peak flow.

At least a 20% rise.

29
New cards

Describe the typical finding on chest auscultation during expiration.

Wheezes that can require forced exhalation to detect and may disappear during severe attacks.

30
New cards

Identify findings not characteristic of asthma

Crackles and inspiratory wheezes as primary features.

31
New cards

List upper airway findings that may coexist.

Signs of allergic rhinitis or nasal polyps.

32
New cards

State an important step when evaluating the patient beyond exam.

Exclude alternative diagnoses.

33
New cards

Name tests that assess airway hyperresponsiveness.

Challenge procedures such as methacholine, histamine, exercise, hyperventilation, or mannitol.

34
New cards

State how challenge tests perform diagnostically.

Moderately sensitive with limited specificity, better for exclusion than confirmation.

35
New cards

Identify two forms of allergy testing used.

Skin prick and serum immunoglobulin E assays.

36
New cards

List imaging's role in this disease.

Evaluate comorbidities, rule out alternative conditions, and find congenital issues.

37
New cards

State how exhaled nitric oxide relates to airway inflammation.

Only modestly linked to eosinophils and insufficient for ruling in or out.

38
New cards

Describe features of the allergic phenotype.

Early onset with personal or family atopy and eosinophilic airway inflammation; typically responsive to inhaled corticosteroids.

39
New cards

Identify the demographic more likely to first present in adulthood.

Women.

40
New cards

State key points for adult‑onset asthma

- Initial presentation later in life

- non‑allergic pattern possible

- higher steroid dose needs

- consideration of work‑related causes.

41
New cards

Describe the non‑allergic asthma

- Later development or persistence from childhood with neutrophilic, eosinophilic, or few inflammatory cells

- shows less immediate steroid response.

42
New cards

Describe persistent airflow limitation asthma

Longstanding disease with incompletely reversible obstruction likely due to structural change.

43
New cards

Describe obesity‑related phenotype.

Prominent respiratory complaints with minimal eosinophilic inflammation.

44
New cards

Describe cough‑predominant phenotype.

Cough is the only symptom and variable flow limitation is absent.

45
New cards

Specify the drop in FEV1 used to define exertional airway narrowing.

10% or greater fall from baseline.

46
New cards

Name typical provoking conditions for exertional airway narrowing.

Cold and dry air as well as airborne allergens.

47
New cards

Describe the diurnal pattern of pulmonary function in asthma

A significant decline occurs overnight with the lowest point around 3-4 am

48
New cards

List contributors that can precipitate nighttime worsening.

- Allergens

- ambient factors

- gastroesophageal reflux

- obstructive sleep apnea,

- sinus disease.

49
New cards

Explain the clinical relevance of nocturnal worsening of asthma

It signals disease severity and poor control.

50
New cards

Summarize the diagnostic strategy in one line.

Combine symptom patterns with variable expiratory flow limitation; there is no single definitive test.

51
New cards

State a prevention takeaway regarding mortality.

Improved care and education can avert most deaths.

52
New cards

Link cellular driver to preferred controller therapy.

Eosinophilic inflammation suggests inhaled corticosteroids.

53
New cards

Link receptor physiology to rescue therapy.

β‑receptors on airway smooth muscle are targeted with β‑agonists.

54
New cards

Name two biologic‑level targets.

Type‑2 interleukins and IgE.